IGM Biosciences Inc expected to post a loss of $1.54 a share - Earnings Preview

IGM Biosciences

25/03/2022 22:41

* IGM Biosciences Inc  IGMS.OQ   IGMS.O  is expected to show
no
change in quarterly revenue when it reports  results on March 28
(estimated). 
    * ​Refinitiv's mean analyst estimate for IGM Biosciences Inc
is
for a loss of $1.54 per share. For the same quarter last year,
the company reported a loss of 79 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for IGM
Biosciences
Inc is $65​, above​ its last closing price of $16.01. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -1.37       -1.37      -1.32     Beat    3.4
 Jun. 30 2021  -1.19       -1.17      -1.16     Beat    0.6
 Mar. 31 2021  -0.96       -0.98      -0.95     Beat    3.1​
 Dec. 31 2020  -0.71       -0.87      -0.79     Beat    9
 ​​Sep.        -0.68       -0.69      -0.66     Beat    4.3
 30 2020                                                
 Jun. 30 2020  -0.64       -0.64      -0.62     Beat    3.9​
 Mar. 31 2020  -0.55       -0.55      -0.58     Missed  -5.5
 Dec. 31 2019              -0.43      -0.49     Missed  -13.3
 This summary was machine generated March 25 at 22:41 GMT.  All
figures in US dollars  unless otherwise stated